Clinical Trial Details
EORTC-20101-23101
Back to Clinical Trials Database
Very early FDG-PET/CT-response adapted therapy for advanced stage Hodgkin Lymphoma (H11), a randomized phase III non-inferiority study of the EORTC Lymphoma Group and the Polish Lymphoma Research Group.
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 20-Mar-2013 Date Step1 close: 08-Apr-2014 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 600 - All Groups: 600 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT01652261 |
| NCT number | NCT01652261 |
| EudraCT | 2011-005473-22 |
